Kevin Reyes

2.3k total citations
22 papers, 234 citations indexed

About

Kevin Reyes is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Kevin Reyes has authored 22 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Kevin Reyes's work include CAR-T cell therapy research (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Multiple Myeloma Research and Treatments (3 papers). Kevin Reyes is often cited by papers focused on CAR-T cell therapy research (5 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Multiple Myeloma Research and Treatments (3 papers). Kevin Reyes collaborates with scholars based in United States and Argentina. Kevin Reyes's co-authors include Charles Y. Chiu, Nina Shah, Rahul Banerjee, Jeffrey L. Wolf, Shagun Arora, Alfred Chung, Chiung‐Yu Huang, Sandy W. Wong, Dianna Ng and Melissa Suter and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Kevin Reyes

17 papers receiving 233 citations

Peers

Kevin Reyes
Nicole Tan Singapore
Jacob K. Files United States
Joseph M. Rocco United States
Shukaib Arslan United States
Aljawharah Alrubayyi United Kingdom
Kiel Shuey United States
Catherine Huntley United Kingdom
Kevin Reyes
Citations per year, relative to Kevin Reyes Kevin Reyes (= 1×) peers Cássia Gisele Terrassani Silveira

Countries citing papers authored by Kevin Reyes

Since Specialization
Citations

This map shows the geographic impact of Kevin Reyes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Reyes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Reyes more than expected).

Fields of papers citing papers by Kevin Reyes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Reyes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Reyes. The network helps show where Kevin Reyes may publish in the future.

Co-authorship network of co-authors of Kevin Reyes

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Reyes. A scholar is included among the top collaborators of Kevin Reyes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Reyes. Kevin Reyes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laliotis, George, Kevin Reyes, Beverly S. Mitchell, et al.. (2025). Association of tumor-informed ctDNA-based molecular residual disease (MRD) with clinical outcomes for upper tract urothelial cancer (UTUC).. Journal of Clinical Oncology. 43(16_suppl). 4565–4565. 1 indexed citations
2.
Reyes, Kevin, Yen‐Chun Liu, Chiung‐Yu Huang, et al.. (2024). Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma. Blood Advances. 8(9). 2207–2216. 15 indexed citations
3.
Vasudevan, Harish N., Ann Lazar, Kevin Reyes, et al.. (2024). Comparison of Plasma Metagenomic Next-generation Sequencing and PCR Methods for Epstein–Barr Virus Viral Load Monitoring in Nasopharyngeal Carcinoma. Anticancer Research. 44(12). 5445–5453.
5.
Reyes, Kevin, et al.. (2024). Unveiling inequities in representation: Racial disparities in supportive care breast cancer clinical trial enrollment.. Journal of Clinical Oncology. 42(16_suppl). 1605–1605.
6.
Reyes, Kevin, Xiaolin Zhu, Chien‐Kuang Cornelia Ding, et al.. (2024). Association of HER2 expression in advanced urothelial carcinoma (aUC) and treatment outcomes with immune checkpoint inhibitors and enfortumab vedotin.. Journal of Clinical Oncology. 42(4_suppl). 599–599. 2 indexed citations
7.
Reyes, Kevin, Chiung‐Yu Huang, Mimi Lo, et al.. (2023). Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma. Transplantation and Cellular Therapy. 29(6). 350–355. 26 indexed citations
8.
Zhu, Xiaolin, Li Zhang, Kevin Reyes, et al.. (2023). Association of biomarkers and response to immune checkpoint inhibitors (ICIs) in patients with metastatic urothelial carcinoma (mUC) with high and low tumor mutation burden (TMB).. Journal of Clinical Oncology. 41(6_suppl). 534–534. 2 indexed citations
9.
Reyes, Kevin, Li Zhang, Xiaolin Zhu, et al.. (2023). Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).. Journal of Clinical Oncology. 41(6_suppl). 532–532. 3 indexed citations
10.
Reyes, Kevin, et al.. (2023). Effect of Structure to Promote Organic Residue Removal during Cu Post-Chemical Mechanical Planarization (p-CMP) Cleaning. ECS Meeting Abstracts. MA2023-02(65). 3134–3134.
11.
Reyes, Kevin, Yen‐Chun Liu, Chiung‐Yu Huang, et al.. (2022). OAB-051: Salvage therapies and clinical outcomes after relapse following BCMA CAR-T in patients with relapsed/refractory multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 22. S31–S32. 1 indexed citations
12.
Morvan, Maelig, Nancy Lee, Zicheng Hu, et al.. (2022). Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19. Frontiers in Genetics. 13. 845474–845474. 18 indexed citations
13.
Reyes, Kevin, Chiung‐Yu Huang, Mimi Lo, et al.. (2022). OAB-008: Efficacy and safety of BCMA-targeted CAR-T therapy in elderly patients with multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 22. S5–S5. 1 indexed citations
14.
Reyes, Kevin, Chiung‐Yu Huang, Mimi Lo, et al.. (2022). Safety and Efficacy of BCMA-Targeted CAR-T Therapy in Geriatric Patients with Multiple Myeloma. Blood. 140(Supplement 1). 5105–5107. 3 indexed citations
15.
Lichter, Katie, Sumi Sinha, Paul Wong, et al.. (2022). Pilot Implementation of a Multidisciplinary Tumor Board Seminar Series to Foster Increased Understanding of and Interest in Oncologic Care Among Medical Students. International Journal of Radiation Oncology*Biology*Physics. 114(1). e15–e16.
16.
Reyes, Kevin, et al.. (2022). A Targeted Interest Survey of Preclinical Medical Students for Implementation of Exposure Opportunities in Multidisciplinary Oncology Education. International Journal of Radiation Oncology*Biology*Physics. 114(1). e23–e23.
17.
Fasching, Clare L., Venice Servellita, James P. Broughton, et al.. (2022). COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme. Journal of Clinical Microbiology. 60(7). e0026122–e0026122. 31 indexed citations
18.
Fung, Monica, Charles Y. Chiu, Catherine DeVoe, et al.. (2020). Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States. American Journal of Transplantation. 20(11). 3225–3233. 54 indexed citations
19.
Gu, Wei, Xianding Deng, Kevin Reyes, et al.. (2020). Associations of Early COVID-19 Cases in San Francisco With Domestic and International Travel. Clinical Infectious Diseases. 71(11). 2976–2980. 6 indexed citations
20.
Seferovic, Maxim D., Suzette D. Tardif, Julienne N. Rutherford, et al.. (2018). Experimental Zika Virus Infection in the Pregnant Common Marmoset Induces Spontaneous Fetal Loss and Neurodevelopmental Abnormalities. Scientific Reports. 8(1). 6851–6851. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026